United States Drug Patent Prices Database 2021: What is the earliest generic entry opportunity date for a drug with dozens of patents?
Dublin, April 30, 2021 (GLOBE NEWSWIRE) -- The "Drug Patent Database Subscription: US Drug Prices" database has been added to ResearchAndMarkets.com's offering.
This subscription was created to answer a simple question: When do drug patents expire? Your needs evolve as the industry keeps changing. Since then dozens of additional datasets have been added by aggressive adaptation based on your needs.
This subscription for the US Drug Prices portion of the database offers information on:
Brand vs. Generic Drug Price Gap, find generic entry opportunities
Average Pharmacy Cost, set reasonable launch prices
Best-Available Price, see price ranges
Global biopharmaceutical markets face constant change. To remain competitive you need to anticipate what's next. The analyst understands and works together with you to help you make better decisions. If you are expanding into new markets, looking inward for growth opportunities, or seeking to improve your current activities and need to find information quickly, this subscription can help.
The analyst provides relevant context and ensures you have the information you need at your fingertips. This helps you see opportunities and enrich your analysis, without overwhelming you with options or asking you to perform many searches. The sophisticated algorithms are also tailored to help you extract valuable insights.
With a single click, you can find answers to complex questions such as:
Which drugs have no patents and no competitors?
What are all the patents covering any given dosage form (e.g. injectables)?
What is the earliest generic entry opportunity date for a drug with dozens of patents?
The analyst focuses on delivering the greatest value and lowest cost by directing attention to high-impact problems, giving you the relevant information you need.
Key Topics Covered:
Brand vs. Generic Drug Price
Average Pharmacy Cost
Best-Available Price
Companies Mentioned
3M Pharmaceuticals
Abbott Laboratories
AbbVie
Acadia Pharmaceuticals
Acorda Therapeutics
Actavis
Actelion
Adcock Ingram
Advanced Chemical Industries
Advaxis
ACG Worldwide
Ajanta Pharma
Alcon
Alembic Pharmaceuticals Ltd
Alexion Pharmaceuticals
Alkaloid AD Skopje
Alkermes
Allergan
Alliance Boots
Almirall
Alphapharm
Altana Pharma AG
Amgen
Anfatis
Apotex Inc.
Aspen Pharmacare
Astellas Pharma
AstraZeneca
Aurobindo Pharma
Avax Technologies
Avella Specialty Pharmacy
Axcan Pharma
Bargn Farmaceutici Phils Co
Barr Pharmaceuticals
Bausch & Lomb
Baxalta
Baxter International
Bayer Schering Pharma AG
Beximco Pharmaceuticals Ltd
Bial
Biocon
Biogen
Biolex
BioMarin Pharmaceutical
Bionovo
Biotecnol
Biovail
Biovitrum
Bluepharma
Boehringer-Ingelheim
Bosnalijek
Bristol-Myers Squibb
BTG plc
Cadila Healthcare
Canadian Plasma Resources
Catalent
The Cathay Drug Co., Inc.
Celgene
Cephalon
Chiesi Farmaceutici S.p.A.
Chugai Pharmaceutical Co.
CinnaGen
Cipla
Clovis Oncology
CoCo Therapeutics
Concordia Healthcare
Covance
Crucell
CSL Limited
Dabur
Daiichi Sankyo
Dainippon Sumitomo Pharma
Dawakhana Shifaul Amraz
Debiopharm
Deurali-Janta Pharmaceuticals
Diabetology Ltd
Diffusion Pharmaceuticals
Dr. Reddy's Laboratories
Ego Pharmaceuticals
Eisai
Elder Pharmaceuticals
Eli Lilly and Company
Emcure Pharmaceuticals
Emergent BioSolutions
Endo Pharmaceuticals
Eskayef Bangladesh Limited
Esteve
F. Hoffmann-La Roche Ltd., which owns Genentech and Chugai Pharmaceuticals
Fabre-Kramer Pharmaceuticals
Ferring Pharmaceuticals
Fresenius Kabi
Fresenius Medical Care
Galderma Laboratories
Gedeon Richter Ltd.
General Pharma
Gilead Sciences
Glatt group
GlaxoSmithKline
Glenmark Pharmaceuticals
GPC Biotech
Grifols
Grindeks
Gulf Pharmaceutical Industries (Julphar)
G.F. Harvey Company
Huadong Medicine
Help Remedies
Hetero Drugs
Hexal Australia
Hikma Pharmaceuticals
Hoffmann-La Roche
Horizon Pharma
Hovione
Incepta Pharmaceuticals
Institute for OneWorld Health
Intas Biopharmaceuticals
Interphil Laboratories
Ionis Pharmaceuticals
Ipca Laboratories
Ipsen
Janssen Pharmaceutica
Jenapharm
JN-International Medical Corporation
Johnson & Johnson
Julphar
Juno Therapeutics
Kimia Farma
Kyowa Hakko Kirin
Lundbeck
Lupin Limited
Mallinckrodt Pharmaceuticals
MannKind Corporation
McGuff
Medinfar
Melior Discovery
Menarini
Merck & Co.
Merck KGaA
Mitsubishi Pharma
Mylan
Mayne Pharma
NovaBay Pharmaceuticals
Novartis
Novo Nordisk
Noxxon
Octapharma
Orexo
OrgaNext
Orion Pharma
Ortho-McNeil Pharmaceutical
Otsuka Pharmaceutical Co.
Panacea Biotec
Par Pharmaceutical
Patheon
Perrigo
Pfizer
Pharmaceutical Product Development
Pharma Medica
Pharma Nord
Pharmacosmos
Pharmascience
Pierre Fabre Group
Piramal Healthcare
Pliva
Procter & Gamble
Purdue Pharma
Ranbaxy Laboratories
Reckitt Benckiser
Regeneron Pharmaceuticals
Renovo PLC
Repligen
Rubicon Research
Salix Pharmaceuticals
Sanofi
Serum Institute of India
Servier Laboratories
Shionogi
Shire plc
SIGA Technologies
Sigma Pharmaceuticals
Sinopharm Group
Solvay Group
Square Pharmaceuticals
STADA Arzneimittel
Strides Arcolab
Sun Pharmaceutical
Sunovion
Takeda Pharmaceutical Co.
Tasly
Teva Pharmaceuticals
Taro Pharmaceuticals
Torrent Pharmaceuticals
Turing Pharmaceuticals
UCB
Unichem Laboratories
USV Private Limited
Valeant Pharmaceuticals International
Veloxis Pharmaceuticals
Vertex Pharmaceuticals
Vion Pharmaceuticals, Inc.
Wallace Pharmaceuticals
Wockhardt
Yuhan Corporation
Zandu Pharmaceuticals
Zentiva
For more information about this database visit https://www.researchandmarkets.com/r/4pah93
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900